ANTIGENICS, INC.

Company

AGENUS INC

Filed

February 9, 2001

Accession Number

0000950135-01-000353

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →